Literature DB >> 1147435

Effects of hematin in hepatic porphyria. Further studies.

G J Dhar, I Bossenmaier, Z J Petryka, R Cardinal, C J Watson.   

Abstract

The present study was carried out in five cases of hepatic porphyria, including three of acute intermittent porphyria, one of variegate porphyria, and one of porphyria cutanea tarda in clinical remission. In two cases of acute intermittent porphyria (in relapse), a marked lowering effect on serum and urine porphobilinogen and delta-aminolevulinic acic was observed, together with prompt and gratifying clinical improvement. In a third case, in chemical remission but with longstanding psychoneurosis, no significant effects were noted, nor were any observed in the case of porphyria cutanea tarda. Although clinical improvements occurred in the case of variegate porphyria, the results were inconclusive for reasons given. Hematin was generally well tolerated. Preliminary reference is made to a transitory renal injury, without sequelae, where an excess of hematin was given in relation to time. Limits of tolerance are proposed. In the light of these observations the basic mechanism of the acute attack is diccussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1147435     DOI: 10.7326/0003-4819-83-1-20

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  25 in total

1.  Perspectives in acute intermittent porphyria.

Authors:  I C Verma; S Singh
Journal:  Indian J Pediatr       Date:  1976-07       Impact factor: 1.967

2.  Porphyria variegata and porphyria cutanea tarda in siblings: chemical and genetic aspects.

Authors:  C J Watson; R A Cardinal; I Bossenmaier; Z J Petryka
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

3.  Catecholamine uptake, accumulation, and release in acute porphyria.

Authors:  M F Beal; N O Atuk; T C Westfall; S M Turner
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

4.  Pharmacokinetics of intravenously administered haem arginate.

Authors:  O Tokola; R Tenhunen; L Volin; P Mustajoki
Journal:  Br J Clin Pharmacol       Date:  1986-09       Impact factor: 4.335

Review 5.  Targeting the Nrf2-Heme Oxygenase-1 Axis after Intracerebral Hemorrhage.

Authors:  Jing Chen-Roetling; Raymond F Regan
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

6.  Hepatic metabolism of heme in rats after exposure to benzene, gasoline and kerosene.

Authors:  G S Rao; K P Pandya
Journal:  Arch Toxicol       Date:  1980-12       Impact factor: 5.153

Review 7.  Management of attacks of acute porphyria.

Authors:  A C Laiwah; K E McColl
Journal:  Drugs       Date:  1987-11       Impact factor: 9.546

8.  Delta-Aminolaevulinic acid and amino acid neurotransmitters.

Authors:  M J Brennan; R C Cantrill
Journal:  Mol Cell Biochem       Date:  1981-08-11       Impact factor: 3.396

9.  Hematin therapy in porphyric attacks.

Authors:  C A Pierach; I Bossenmaier; R Cardinal; M Weimer; C J Watson
Journal:  Klin Wochenschr       Date:  1980-08-15

10.  Haem transport to the liver by haemopexin. Receptor-mediated uptake with recycling of the protein.

Authors:  A Smith; W T Morgan
Journal:  Biochem J       Date:  1979-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.